Expanded Potential Stem Cell lines of pig and human cells established
A new approach has enabled researchers to create Expanded Potential Stem Cells (EPSCs) of both pig and human cells. These stem cells have the features of the very first cells in the developing embryo, and can develop into any type of cell. The research from LKS Faculty of Medicine of The University of Hong Kong (HKUMed), the Wellcome Sanger Institute, and the Friedrich-Loeffler-Institut in Germany offers incredible potential for studying human development and regenerative medicine.
The study published in Nature Cell Biology today (3rd June) is the first time scientists have been able to derive stem cells from early pig embryos. Domestic pigs have great potential for biomedical research because of their genetic and anatomical similarities to humans, including comparable organ sizes. Being able to genetically-modify pig stem cells will also be beneficial for animal health and food production.
Stem cells have the ability to develop into other cell types, and existing stem cell lines are already extremely useful for research into development, disease and treatments. However, currently available types of stem cell lines have limitations, and until now it has also not been possible to create embryonic stem cells from pigs and many other farm animals.
“Scientists have been attempting to derive porcine embryonic stem cells for decades without much success. With our Expanded Potential Stem Cell technology, we have now successfully derived and characterised stem cells from porcine preimplantation embryos. We have also established similar human stem cells. Our study represents a significant advance in stem cell research.”
Professor Pentao Liu, the leader of the study from the School of Biomedical Sciences and Stem Cell and Regenerative Medicine Consortium, HKUMed, and previously of the Wellcome Sanger Institute
Since human EPSCs can produce large numbers of placenta cells – called trophoblasts – they offer new opportunities to investigate pregnancy complications such as pre-eclampsia and miscarriages.
EPSCs come from culturing cells from the earliest stage of development, when the fertilised egg has only divided into 4 or 8 cells and the cells retain some totipotency – the ability to produce all cell types.
“These EPSC stem cells possess developmental potency that is not generally seen in conventional embryonic or induced pluripotent stem cells. They have the potential to produce all embryonic and extra-embryonic cell lines – including those in the placenta and yolk sac, turning back the development clock to the very earliest cell type. These cells will enable researchers to study early embryonic development, miscarriage and developmental disorders.”
Dr Xuefui Gao, a first author on the paper from HKUMed, and previously from the Wellcome Sanger Institute
The first EPSCs were created in 2017, when the group targeted key molecular pathways during very early development in mice. At these very earliest embryonic developmental stages, mammalian species are very similar and the cells are like a blank sheet of paper. This study has shown that it is possible to use the same approach to create human EPSCs and also to establish EPSCs from pigs – mammals that had previously been elusive to stem cell researchers.
“Our porcine EPSCs isolated from pig embryos are the first well-characterized pig cell lines worldwide. EPSC’s great potential to develop into any type of cell provides important implications for developmental biology, regenerative medicine, organ transplantation, disease modelling, and screening for drugs.”
Dr Monika Nowak-Imialek, an author on the paper from the Friedrich-Loeffler-Institut (FLI) in Germany
The Latest on: Stem cells
via Google News
The Latest on: Stem cells
- Stem cell study offers new way to study early development and pregnancyon October 17, 2019 at 11:40 am
The adult cells were put into a chemical solution that prompted them to turn into induced pluripotent stem cells, or iPSCs, which can turn into almost any kind of tissue in the body. To encourage the ...
- First generation of induced pluripotent stem cells from domestic catson October 17, 2019 at 9:47 am
Researchers have reported for the first time producing feline induced pluripotent stem cells (fiPSCs) from adult cells of domestic cats. The methods and implications of this research are published in ...
- Hope Biosciences Opens First Phase I/II Stem Cell Trial for Brain Injury Treatmenton October 17, 2019 at 7:51 am
... always been limited by the inability to provide enough cells to make a significant, lasting impact. This trial is novel in that it overcomes these limitations. Due to our proprietary technology, ...
- Dublin mum with MS hopes to travel to Mexico for life-changing stem cell treatmenton October 17, 2019 at 7:04 am
A Dublin woman with MS hopes to travel to Mexico to receive life-changing stem cell treatment. Sinead Costello, 48, was diagnosed with a rare form of MS called Progressive-Relapsing MS (PRMS). The ...
- Alliance for Stem Cell Therapy Now and American Academy of Stem Cell Physicians Hosting Safety Industry Panelon October 16, 2019 at 7:42 pm
Alliance for Stem Cell Therapy Now Ms. Janet Marchibroda will moderate the Safety industry panel hosted by AASCP in Miami on November 2, 2019 and will be broadcast live. MIAMI, Oct. 16, 2019 ...
- Tolerance regeneration by T regulatory cells in autologous haematopoietic stem cell transplantation for autoimmune diseaseson October 16, 2019 at 9:48 am
Autologous haematopoietic stem cell transplantation shows increasing promise as a therapeutic option for patients with treatment-refractory autoimmune disease, particularly systemic sclerosis and ...
- Antibody eradicates leukemia stem cellson October 16, 2019 at 5:36 am
Now, in experiments in mice as well as isolated human cancer cells, UCLA researchers have discovered a way to eliminate the CML stem cells. Their approach uses an antibody to block a protein that the ...
- Adipose Derived Stem Cell Therapy Market Increase at Steady Growth and Forecast 2026on October 16, 2019 at 3:16 am
Oct 16, 2019 (WiredRelease via COMTEX) -- Growing demand for adipose-derived stem cell therapy across medical and biotechnology fields owing to its effectiveness along with a rising number of research ...
- Stem Cell Media Market 2019: Development Status, Sales Revenue, Key Players Analysis and Industry Expansion Strategies 2026on October 15, 2019 at 8:11 am
Oct 15, 2019 (Market Prediction via COMTEX) -- In 2018, the Stem Cell Media Market revenue was around US$ XX Mn and the Market share was XX%, and it will be projected to reach US$ XX Mn and XX% in ...
- Pharmacology Safety Studies Using Neural Stem Cellson October 15, 2019 at 1:27 am
With this being the case, how can human drug screening models be generated without using invasive techniques? Induced pluripotent stem cells (iPSCs) could be the answer. Ideally, iPSC-derived models ...
via Bing News